Good Afternoon and welcome to HotCopper Highlights for Week 36, I’m Jon Davidson. In this segment the stocks you were watching and discussing the most this week on Australia’s number 1 finance website, let’s kick off with the most viewed.
4DS Memory by far the most watched and most discussed stock on Friday after it released a doozy of a strategic review in which the company says it will now conduct another strategic review. The microchip tech player’s main product was proven to be more or less worthless when it came to boosting chip memory in recent final stage testing, which prompted the company last week to begin a strategic review.
It then broke its own deadline for that initial report, extending a voluntary suspension, and now on Friday, the company’s confirmed it will be walking away from its main tech partners and will probably just pivot into AI. Make of that what you will, in this market, anything could happen.
Meanwhile, niobium refractory powder player Amaero generated chatter this week after it inked a deal with ASX listed cold weld specialists Titomic, a like-minded company when it comes to securing critical components for Australia’s defence industry – and that of the US Navy. The great military spending thematic rolls on, showing that it really is a market for guns and gold.
Finally, Terra Uranium among the most viewed, the company has seen monthly gains of around +120% intraweek as that company has given up on the nuclear fuel feedstock and instead gone into rare earths and antimony exploration, not unlike many former lithium juniors currently searching for gold. The keyword here is antimony, that critical mineral which for some reason gets a lot more love than all of the others – largely due to its role in defence, which is also hot.
And so what about the most discussed stocks?
Invictus Energy remains a popular topic to discuss on the forums as a legion of long-term shareholders shout “I told you so” after the company recently saw a 19% stake picked up by the Qatari royal family for $40M as that dynasty seeks to expand its gasfield assets across Africa, including Zimbabwe. The company’s really just had some good luck, but don’t tell that to true believers who engage with the company’s very active investor relations team.
Botanix Pharmaceuticals meanwhile still generating chatter on the forums after the company’s momentum expired a few months ago, that was when its key drug Sofdra, treating an excessive sweat condition, was proven to be less revenue-generating than thought, quickly planting nails in the coffin for what had been a biotech darling through the first six months of the year. On Friday, it reported a regulatory approval in Korea for another product.
Finally, 4D Medical – not to be confused with 4DS Memory – continues to remain a hotspot of attention as its share price has basically been climbing all week defying gravity for an impressive stretch of time, that was after a proposed change to the US medicare system for skin graft and wound healing tech laid open a possibility for far greater sales generation in the leading global economy’s healthcare market.
That’s HotCopper Highlights for Week 36, I’m Jon Davidson, have a great weekend and we’ll see you on Monday.